Actively Recruiting
Internet-Delivered Psychotherapy to Treat Post-Traumatic Stress Disorder After Sexual Abuse Using Restory Program
Led by Karolinska Institutet · Updated on 2026-05-27
140
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
G
Göteborg University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate Restory, a newly developed anonymous internet-delivered cognitive behavioral therapy (iCBT) program focused on prolonged exposure therapy specifically designed for adult victims of sexual abuse with PTSD. The study investigates whether Restory is more effective than a waitlist control in reducing PTSD symptom severity. This trial responds to the need for accessible, low-threshold treatment options that address stigma, shame, and confidentiality concerns common among sexual abuse survivors, including underserved minority groups and males. Participants in the study are randomly assigned to either the Restory treatment group or a waitlist control group. Restory consists of eight weekly modules that combine core prolonged exposure therapy elements with targeted psychoeducation about shame, guilt, disgust, and sexuality. Each module includes educational content, explanations of the therapy, homework assignments, and personalized therapist feedback. The waitlist group waits at least nine weeks before starting treatment but completes the same assessments during the waiting period. During the study, participants complete questionnaires at baseline, after eight weeks of treatment or waitlist, and at one- and six-month follow-ups to measure PTSD severity using tools like PCL-5 and ITQ, as well as depressive symptoms with MADRS-S. The study tracks symptom changes, safety, and adherence to the program. Participation involves self-referral and registration via an online platform, enabling flexible and private access to care without physical clinic visits. The total study duration includes treatment and follow-up assessments over several months.
CONDITIONS
Brief Title
A Randomised Waitlist Controlled Clinical Trial of the Restory Treatment Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Experienced sexual violence with at least 1 month since the incident
- Self-reported PTSD symptom severity score of 30 or higher on PCL-5
- Stable dose of psychotropic medication for at least 4 weeks or medication free
- Sufficient skills in Swedish language
- Willingness and availability to participate in the study
You will not qualify if you...
- Ongoing trauma-related threat such as living with a violent spouse
- Severe psychiatric illness needing immediate alternative treatment (e.g., high suicide risk or psychotic episode)
- Currently receiving other trauma-focused CBT or Eye Movement Desensitization and Reprocessing therapy
- Current benzodiazepine treatment
- No trauma memory available
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 8 weeks
Participants complete the Restory program, an internet-delivered cognitive behavioral therapy tailored for victims of sexual abuse, consisting of eight modules over eight weeks with personalized therapist feedback.
Weekly online sessions
Duration - 6 months
Participants are monitored after completing treatment to assess PTSD and related symptoms at 1 month and 6 months post-treatment.
2 follow-up assessments
Trial Site Locations
Total: 1 location
1
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet
Stockholm, Sweden, 11364
Actively Recruiting
Research Team
M
Malin Joleby, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here